John E. (Jack) Bailey Jr. - 10 May 2023 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
President and CEO, Director
Signature
/s /Sandi James, attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 May 2023
Net transactions value
$0
Form type
4
Filing time
12 May 2023, 16:16:31 UTC
Previous filing
05 Jan 2023
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +160,000 +58% $0.000000 436,282 10 May 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on May 10, 2024 and 50% on May 10, 2025, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 89,971 shares of common stock; (ii) 71,111 RSUs from award granted on January 1, 2021; (iii) 34,500 RSUs from award granted on January 3, 2022; (iv) 80,700 RSUs from award granted on January 3, 2023; and (v) 160,000 RSUs from award granted on May 10, 2023.